medical research

Digital

Blockchain: Ready to revolutionise medicinal cannabis resear...

Robert Galarza outlines how blockchain technology can be utilised to verify, validate and standardise the efficacy of medical cannabis and oth

R&D

Research charity crisis affects the whole development ecosys...

Hopes that the UK government would step in to support charity-funded medical research were dashed when the sector received no mention in the Budget despite campaigns to secure additional su

News

Chiesi signs $1.9bn deal to buy KalVista and its HAE drug

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Using AI-driven synthetic personas to take your insights fur...

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.

Editor's Picks